Disclosure of shareholdings

Current report No. 5/2012

Dated 13 January 2012

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that on January 06 2012 the Company bought 11 150 shares from the capital of the company Hydroizomat AD. With this deal Sopharma AD has increased its holdings in the capital of the above-mentioned company over 5%. Sopharma AD now holds 65 222 shares or 5.02% of the capital of Hydroizomat AD. The total capital of the company is 1 299 122 shares.

The transaction was conducted on the unofficial market of the Bulgarian Stock Exchange – Sofia AD Segment B.

This transaction was not carried out with the purpose of gaining control.

Sopharma AD is not a member of the management board of Hydroizomat AD.